COVID-19-CURE

U of U researching new and old meds for possible coronavirus treatment

Apr 30, 2020, 10:59 AM
coronavirus treatment...
(Hydroxychloroquine tablets in a blister pack. Credit: Buda Mendes, Getty Images)
(Hydroxychloroquine tablets in a blister pack. Credit: Buda Mendes, Getty Images)

SALT LAKE CITY – As the number of COVID-19 patients continues to climb across the country, some doctors say people are desperate to find any kind of coronavirus treatment.  Researchers at the University of Utah are trying to find ways to tackle the virus, and one of them involves a new kind of drug. 

Convalescent plasma.  Antibody testing.  Scientists all over the nation looking down many different avenues to find a way to prevent the spread of SARSCoV-2.  Researchers at the U have come across a relatively new way to treat viruses, in general, involving something that’s already in the body. 

They’re called peptides, and they’re chains of amino acids that naturally form in humans.  Insulin is an example of this.  However, Biochemistry Professor Dr. Michael Kay says they’re making artificial peptides called d-peptides.

“These are peptides that are the mirror images of natural peptides,” he said.

The best analogy we could think of

Think of Mission Impossible, and how the good guys disguise themselves to trick the bad guys to do what they want.  In a way, d-peptides work like that.  Viruses see these things like regular peptides, but, the epithelial cells in the body don’t recognize them at all.

Kay says, “The body doesn’t know what to do with them.  It’s not able to digest them.  It’s not able to reject them through the immune system.  They’re, essentially, stealth agents that are able to roam the body undetected.”

University researchers have been making d-peptides to target HIV, and the results have been quite good.  Eventually, they should be able to custom make a d-peptide to go after coronavirus.

“If it has a d-peptide bound on its surface, it is unable to fuse with the human cell and it just stays outside.  So, infection never even starts,” Kay says.

Plus, Kay says with what they’ve learned from their HIV studies, they should be able to speed up the drug making process for other viruses.  So, how soon can they make it for COVID-19?

He says, “The absolute fastest it could be, if everything went perfectly, is probably two to three years.”

So, it’s a ways off. 

Coronavirus treatment options

Doctors say that’s why there is so much research across the country about existing drugs and how they impact COVID-19.  Just yesterday, Doctor Anthony Fauci reported the drug remdesivir showed fantastic results, but, that doesn’t mean that research into drugs like hydroxychloroquine has stopped.

General internist, Dr. Rachel Hess, says, “The majority of the hydroxychloroquine data that we’ve seen has been in the inpatient setting.  So, it’s trying to take people who are already quite sick with COVID-19 and asking, ‘Can hydroxycholorquine make them better?’”

Hess says that’s a lot of pressure to put on one drug, especially since there are underlying health factors that could play a role in someone’s illness.

“We are looking at hydroxychloroquine vs. placebo in people over the age of 18.  [We’re] enrolling about 400 people,” she says.

She also says there is a lot of conflicting news about hydroxychloroquine.  Hess confirms the data is not promising when it’s used on hospital patients.  However, her study asks what would happen if they use it before the person is seriously ill.

“From the preliminary data, if hydroxychloroquine is going to be helpful, we think it’s going to be helpful earlier in the disease course,” she says.

For now, she says it’s far too early to predict what will happen in their double-blind study.

RELATED LINKS

Drug shows promise in speeding recovery from COVID-19

State of Utah receives refund of the $800 thousand purchase of hydoxychloroquine

4 ways to promote better mental health during the COVID-19 pandemic


How To Prevent the Spread of COVID-19 Coronavirus

COVID-19 coronavirus spreads person to person. It is a virus that is similar to the common cold and the flu. So, to prevent it from spreading:

  • Wash hands frequently and thoroughly, with soap and water, for at least 20 seconds.
  • Don’t touch your face.
  • Keep children and those with compromised immune systems away from someone who is coughing or sneezing (in this instance, at least six feet)
  • If there is an outbreak near you, practice social distancing (stay at home, instead of going to the movies, sports events, or other activities.)
  • Get a flu shot.

Local resources

KSL Coronavirus Q&A 

Utah’s Coronavirus Information 

Utah State Board of Education

Utah Hospital Association

The Church of Jesus Christ of Latter-day Saints

Utah Coronavirus Information Line – 1-800-456-7707

National Resources

Centers for Disease Control and Prevention

Commonly asked questions, World Health Organization

Cases in the United States

Today’s Top Stories

COVID-19-Cure

utah covid children...
Paul Nelson

Researchers believe ‘omicron’ variant will be in Utah, sooner or later

SALT LAKE CITY – Health officials in Utah say they’re keeping a close eye on the new COVID variant (omicron variant) coming out of South Africa, but how worried should we be in the Beehive State?  Researchers say it’s likely going to come to Utah, the real question is “when?” Omicron variant Officials with the […]
1 day ago
SHORELINE, WA - NOVEMBER 03: A firefighter prepares pediatric doses of the Pfizer-BioNtech Covid-19...
MICHAELEEN DOUCLEFF NPR

Studies find evidence of ‘Superhuman’ immunity to COVID-19

In an article released by NPR, some scientists are reporting “superhuman immunity” present in defending against COVID-19. This is also known as “hybrid immunity.” The article explains that scientists have discovered that certain individuals are able to produce an extremely powerful immune response against SARS-CoV-2, the coronavirus responsible for COVID-19. These individuals produce very high […]
17 days ago
Pfizer COVID-19 pill...
MATTHEW PERRONE AP Health Writer

Pfizer says COVID-19 pill cut hospital, death risk by 90%

Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. The company announced Friday it will soon ask the U.S. Food and Drug Administration and international regulators to authorize its pill, which is taken twice a day for five days.
22 days ago
utah covid children...
Paul Nelson

Doctors report more COVID-19, and MIS-C cases in Utah kids

In Utah, children between the ages of five and 11 make up 20% of new COVID-19 cases, and 120 kids have another illness, MIS-C.
29 days ago
FILE  - In this undated file image provided by Merck & Co. shows their new antiviral medication...
The Associated Press

Merck agrees to let other drug makers produce its COVID pill

Merck's COVID-19 treatment is the first pill with demonstrated effectiveness. Millions of people in poorer countries could gain access to the drug.
1 month ago
Council of Governors...
Lindsay Aerts

Governor Spencer Cox says decision to vaccinate should be left up to businesses

Governor Cox wants to businesses to decide for themselves if COVID-19 vaccines should be required.
2 months ago
U of U researching new and old meds for possible coronavirus treatment